The incidence of broad-definition AESIs in older vaccinees was generally comparable to younger adults, with a slight trend toward lower rates as age increased, although overall, age was considered to have no impact on the overall safety profile of VLA1553.
← all excerpts
Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ<sup>®</sup>).
1
—
—